Evotec is particularly focused on expanding its biologics capabilities to meet increased demand for complex biologics manufacturing and broaden its offerings to customers. We expect the company will ...

A new discovery could pave the way for more effective cancer treatment by helping certain drugs work better inside the body.

Interested in finding a better way to develop drugs to treat amyotrophic lateral sclerosis (ALS), Northeastern researcher ...

The rise of life science startups is revolutionizing healthcare, leveraging biotechnology to address critical health ...

AMPLY, the company behind the proprietary AMPLYfolioAI platform, is accelerating the discovery of new medicines for complex ...

ProFuse's novel technology addresses the growing need to preserve muscle in the face of aging and the popularity of ...

NU-9 targets a shared underlying mechanism found in various neurodegenerative diseases. A new study from Northwestern ...

Choosing between plate reader-based assays and mass spectrometry solutions is a key decision for scientists when evaluating ...

Protagonist Therapeutics, Inc. (”Protagonist” or the “Company”), a clinical-stage biopharmaceutical company pioneering the discovery and development of peptide-based therapeutics, today announced that ...

CMND-100 is Clearmind’s proprietary MEAI-based oral drug candidate, developed as a potential breakthrough treatment for AUD. Unlike traditional treatment methods, CMND-100 is designed to offer a novel ...

Elix Inc. has entered into a drug discovery collaboration with Prism Biolab Co. Ltd. to accelerate AI-driven drug discovery for challenging protein-protein interaction targets. The partnership will ...

Johnson & Johnson, while primarily known as America's leading healthcare company, now employs nearly 7,000 digital specialists and data scientists.